Betachem Recalls Metformin Hydrochloride API Due to CGMP Deviations
Betachem, Inc. is recalling 27,000 kilos of Metformin Hydrochloride USP active pharmaceutical ingredient because it was not manufactured according to current good manufacturing practices.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity recall involving potential quality issues without confirmed harm.
Plain-English summary
Betachem, Inc. is recalling 27,000 kilos (1,080 drums) of Metformin Hydrochloride USP, an active pharmaceutical ingredient (API) intended for manufacturing, processing, or re-packing use only. The product is distributed in 25 kg drums and is marked for prescription use only. The API was manufactured by Smruthi Organics Limited in India.
The recall was initiated because the active pharmaceutical ingredient was not manufactured according to current good manufacturing practices (CGMP). The source text does not specify the exact nature of the deviations or report any illnesses, injuries, or deaths associated with the product.
The affected product is distributed in Missouri (MO). Specific lot numbers involved in the recall include DMFH-366/11 through DMFH-406/11, with specific gaps in the sequence as listed in the source data. Because this is an active pharmaceutical ingredient for manufacturing use, it is not intended for direct consumer use. Healthcare facilities and manufacturers should stop using the affected lots and contact the recalling firm for instructions.
The recalled product
- Product
- Metformin Hydrochloride USP, Active Pharmaceutical Ingredient for manufacturing, processing or re-packing use only, 25 kg drum, Rx only, Manufactured by: Smruthi Organics Limited, Plot No.: A-27 M.I.D.C., Chincholi, Taq.: Mohol, Solapur-413 255. Maharashtra, India; NDC No. 10828-
- Manufacturer
- Betachem, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: DMFH-366/11
- DMFH-367/11
- DMFH-368/11
- DMFH-369/11
- DMFH-370/11
- DMFH-371/11
- DMFH-372/11
- DMFH-373/11
- DMFH-374/11
- DMFH-375/11
- DMFH-376/11
- DMFH-393/11
- DMFH-394/11
- DMFH-395/11
- DMFH-396/11
- DMFH-397/11
- DMFH-399/11
- DMFH-400/11
- DMFH-401/11
- DMFH-402/11
Distribution
Distributed in 1 state:
Related recalls
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19